Navellier & Associates Inc. Grows Stock Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

Navellier & Associates Inc. raised its position in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 86.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 45,627 shares of the company’s stock after purchasing an additional 21,141 shares during the period. Navellier & Associates Inc. owned approximately 0.13% of The Pennant Group worth $1,210,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. FMR LLC raised its position in The Pennant Group by 51.3% during the third quarter. FMR LLC now owns 2,528,512 shares of the company’s stock valued at $90,268,000 after purchasing an additional 856,838 shares in the last quarter. Van Berkom & Associates Inc. raised its position in The Pennant Group by 2,635.6% during the fourth quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company’s stock valued at $58,297,000 after purchasing an additional 2,117,859 shares in the last quarter. Crewe Advisors LLC raised its position in The Pennant Group by 1.6% during the third quarter. Crewe Advisors LLC now owns 742,958 shares of the company’s stock valued at $26,524,000 after purchasing an additional 11,927 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of The Pennant Group by 0.4% during the third quarter. Geode Capital Management LLC now owns 682,132 shares of the company’s stock valued at $24,357,000 after buying an additional 2,963 shares during the last quarter. Finally, De Lisle Partners LLP grew its stake in shares of The Pennant Group by 7.6% during the third quarter. De Lisle Partners LLP now owns 343,340 shares of the company’s stock valued at $12,254,000 after buying an additional 24,321 shares during the last quarter. Hedge funds and other institutional investors own 85.88% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on PNTG shares. Truist Financial reduced their price objective on The Pennant Group from $38.00 to $32.00 and set a “hold” rating on the stock in a research note on Monday, January 6th. Oppenheimer raised their target price on The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a research note on Friday, November 8th. Finally, Wells Fargo & Company started coverage on The Pennant Group in a research note on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.00.

The Pennant Group Trading Down 2.8 %

NASDAQ:PNTG opened at $25.05 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.58. The Pennant Group, Inc. has a 12 month low of $16.28 and a 12 month high of $37.13. The company has a market cap of $860.47 million, a PE ratio of 36.84, a price-to-earnings-growth ratio of 2.24 and a beta of 1.91. The company has a 50 day simple moving average of $26.93 and a two-hundred day simple moving average of $30.70.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.